Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
Caso V, de Groot JR, Sanmartin Fernandez M, Segura T, Blomström-Lundqvist C, Hargroves D, Antoniou S, Williams H, Worsley A, Harris J, Caleyachetty A, Vardar B, Field P, Ruff CT. Caso V, et al. Among authors: caleyachetty a. Heart. 2023 Jan 11;109(3):178-185. doi: 10.1136/heartjnl-2022-321114. Heart. 2023. PMID: 36316100 Free PMC article.
Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare.
Blankenburg M, Sánchez-Collado I, Soyemi BO, Åkerborg Ö, Caleyachetty A, Harris J, Morris E, Newstead G, Lobig F. Blankenburg M, et al. Among authors: caleyachetty a. J Med Econ. 2023 Jan-Dec;26(1):850-861. doi: 10.1080/13696998.2023.2222035. J Med Econ. 2023. PMID: 37278659 Free article.
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
Blomström Lundqvist C, Själander S, Garcia Rodriguez LA, Åkerborg Ö, Jin G, Caleyachetty A, Huelsebeck M, Bowrin K, Schaefer B, Mahdessian H, Hofmeister L, Levin LÅ. Blomström Lundqvist C, et al. Among authors: caleyachetty a. J Med Econ. 2022 Jan-Dec;25(1):1085-1091. doi: 10.1080/13696998.2022.2116848. J Med Econ. 2022. PMID: 35997241 Free article.